Apr 04
The following companies has recently had stock analysts initiate, upgrade or downgrade coverage on them. The analysis is detailed below.
Upgraded Coverage
- Comtech Telecom(CMTL)
Noble Financial has upgraded their rating
from: Hold – to – Buy (Target Price: $40.00)
- Fifth Third(FITB)
Stifel Nicolaus has upgraded their rating
from: Hold – to – Buy (Target Price: $17.00)
- Global Payment(GPN)
Stifel Nicolaus has upgraded their rating
from: Hold – to – Buy (Target Price: $54.00)
- First Potomac Realty(FPO)
Hilliard Lyons has upgraded their rating
from: Long-term Buy – to – Buy (Target Price: $14.00)
Downgraded Coverage
- Best Buy(BBY)
McAdams Wright Ragen has downgraded their rating
from: Buy – to – Sell
- Coca-Cola(KO)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- Keryx Biopharma(KERX)
Ladenburg Thalmann has downgraded their rating
from: Buy – to – Neutral
- U.S. Bancorp(USB)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- Netflix(NFLX)
Barclays has downgraded their rating
from: Overweight – to – Equal Weight (Target Price: $115.00)
Tagged with: BBY • CMTL • FITB • FPO • GPN • KERX • KO • NFLX • USB
Apr 19
The following companies has recently had stock analysts initiate, upgrade or downgrade coverage on them. The analysis is detailed below.
Upgraded Coverage
- AU Optronics(AUO)
Avian has upgraded their rating
from: Neutral – to – Positive
- Hyatt Hotels(H)
FBR Capital has upgraded their rating
from: Mkt Perform – to – Outperform (Target Price: $49.00)
- LG Display(LPL)
Avian has upgraded their rating
from: Neutral – to – Positive
- Mission West(MSW)
Stifel Nicolaus has upgraded their rating
from: Hold – to – Buy (Target Price: $7.50)
- Norfolk Southern(NSC)
BB&T Capital Mkts has upgraded their rating
from: Hold – to – Buy
Downgraded Coverage
- ManTech(MANT)
RBC Capital Mkts has downgraded their rating
from: Sector Perform – to – Underperform (Target Price: $42.00)
- HHGregg(HGG)
KeyBanc Capital Mkts has downgraded their rating
from: Buy – to – Hold
- Community Health(CYH)
Oppenheimer has downgraded their rating
from: Outperform – to – Perform
- Celanese(CE)
UBS has downgraded their rating
from: Buy – to – Neutral (Target Price: $48.00)
- Bronco Drilling(BRNC)
Global Hunter Securities has downgraded their rating
from: Accumulate – to – Neutral (Target Price: $11.00)
- Best Buy(BBY)
KeyBanc Capital Mkts has downgraded their rating
from: Buy – to – Hold
- Papa John’s(PZZA)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
Tagged with: AUO • BBY • BRNC • CE • CYH • H • HGG • LPL • MANT • MSW • NSC • PZZA
Mar 24
The following companies have scheduled their company earnings to be released today, Thursday, March 24, 2011.
Tagged with: ACN • BBY • BODY • CAG • CHRS • CSUN • CTP • FINL • ORCL • PRMW • SMOD • SNX • UTIW
Dec 16
The following companies has recently had stock analysts initiate, upgrade or downgrade coverage on them. The analysis is detailed below.
New Coverage
Upgraded Coverage
- Hertz Global(HTZ)
Barclays Capital has upgraded their rating
from: Equal Weight – to – Overweight (Target Price: $20.00)
- Ryder System(R)
RBC Capital Mkts has upgraded their rating
from: Sector Perform – to – Outperform (Target Price: $62.00)
- First Horizon(FHN)
Morgan Keegan has upgraded their rating
from: Mkt Perform – to – Outperform (Target Price: $14.00)
- HCP(HCP)
Robert W. Baird has upgraded their rating
from: Neutral – to – Outperform (Target Price: $37.00)
- International Coal(ICO)
Brean Murray has upgraded their rating
from: Hold – to – Buy (Target Price: $9.00)
Downgraded Coverage
- Alcon(ACL)
Collins Stewart has downgraded their rating
from: Buy – to – Hold (Target Price: $168.00)
- Cabela’s(CAB)
Feltl & Co. has downgraded their rating
from: Strong Buy – to – Buy (Target Price: $26.00)
- Tesoro(TSO)
Howard Weil has downgraded their rating
from: Market Outperform – to – Market Perform (Target Price: $20.00)
- Stryker(SYK)
UBS has downgraded their rating
from: Buy – to – Neutral (Target Price: $55.00)
- Pacer Intl(PACR)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- JB Hunt Trans(JBHT)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- Hub Group(HUBG)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- Crestwood Midstream Partners(CMLP)
UBS has downgraded their rating
from: Buy – to – Neutral (Target Price: $27.50)
- Best Buy(BBY)
Oppenheimer has downgraded their rating
from: Outperform – to – Perform (Target Price: $39.00)
- FMC Tech(FTI)
Barclays Capital has downgraded their rating
from: Overweight – to – Equal Weight (Target Price: $83.00)
Tagged with: ACL • BBY • BEXP • CAB • CHH • CMLP • ELGX • FCF • FHN • FNB • FTI • FULT • GDP • GET • GM • H • HAS • HCP • HOT • HTZ • HUBG • ICO • IHG • IRM • JBHT • JCI • KOP • MAR • MDF • MTN • NPBC • NUVA • PACR • PPO • PRMW • R • SUSQ • SYK • TFM • TSO • WYN
Dec 15
The following companies has recently had stock analysts initiate, upgrade or downgrade coverage on them. The analysis is detailed below.
New Coverage
Upgraded Coverage
- Best Buy(BBY)
Standpoint Research has upgraded their rating
from: Hold – to – Buy (Target Price: $42.00)
- Dynamic Materials(BOOM)
DA Davidson has upgraded their rating
from: Neutral – to – Buy (Target Price: $24.00)
- Genoptix(GXDX)
Avondale has upgraded their rating
from: Mkt Perform – to – Mkt Outperform (Target Price: $28.00)
- TRW Automotive(TRW)
KeyBanc Capital Mkts has upgraded their rating
from: Hold – to – Buy (Target Price: $69.00)
- Tutor Perini(TPC)
UBS has upgraded their rating
from: Neutral – to – Buy (Target Price: $30.00)
Downgraded Coverage
- Aixtron(AIXG)
Kaufman Bros has downgraded their rating
from: Buy – to – Hold (Target Price: $37.00)
- Toreador Royalty(TRGL)
Stifel Nicolaus has downgraded their rating
from: Buy – to – Hold
- Masco(MAS)
Ticonderoga has downgraded their rating
from: Neutral – to – Sell (Target Price: $10.75)
- Kaiser Alum(KALU)
UBS has downgraded their rating
from: Buy – to – Neutral (Target Price: $54.00)
- Cepheid(CPHD)
Wedbush has downgraded their rating
from: Outperform – to – Neutral (Target Price: $23.00)
- Acorda Therapeutics(ACOR)
Robert W. Baird has downgraded their rating
from: Outperform – to – Neutral (Target Price: $31.00)
Tagged with: ACOR • AIXG • APRI • ATU • AUGT • BBY • BCSI • BOOM • BP • CMI • COP • CPHD • DVA • E • EJ • EXAS • FAST • FMS • GEOY • GWW • GXDX • IEX • KALU • KID • LII • MAS • OCLS • TOT • TPC • TRGL • TRW • WSO • XOM